Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Marc Elia currently holds 10,700,000 shares of Adagio Therapeutics, Inc. (ADGI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marc Elia has been a net buyer of ADGI stock. They have purchased $12.2M and sold $0 worth of shares.
Marc Elia's most recent insider trade was on Aug 30, 2026, when they sold 10,700,000 shares at $0.00 per share.
Marc Elia serves as Executive at Adagio Therapeutics, Inc. (ADGI). They have executed 5 insider transactions totaling $12.2M over their tenure at the company.
Marc Elia holds the position of Executive at Adagio Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Marc Elia has shown a buying trading pattern, with $12.2M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Marc Elia was on Aug 18, 2022, when they purchased $5.5M worth of ADGI shares. This transaction involved 1,265,549 shares at $4.31 per share.
Marc Elia currently owns 10,700,000 shares of Adagio Therapeutics, Inc. (ADGI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Marc Elia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Marc Elia has 5 Form 4 filings on record as an insider at Adagio Therapeutics, Inc..
Set alerts for Marc Elia and 40,000+ other insiders.